What can consumers expect from a marijuana debt consolidation?

Most of the industry was enthusiastic about the progress of the rescheduling. But what does this mean for the over 40 million consumers in the real world?

The federal government has taken a major step to reclassify marijuana from Schedule 1, a dangerous drug with no medical use, to Schedule III like ketamine, Tylenol with codeine and anabolic steroids. The industry is enthusiastic about the progress. Benefits include the ability to take a simple tax write-off like any other regular mom-and-pop business. But what can consumers expect from a marijuana debt consolidation?

RELATED: Beer sales are down thanks to marijuana

Two longer term benefits. With an Appendix III classification, medical researchers may find it easier to obtain the necessary approvals and funding for studies. Based on existing work, scientists have just begun to figure out how the plant can help the body. With a better understanding of the compound's potential, better treatment options will be available for a variety of health problems. The pharmaceutical industry, the leading research location, will benefit from the expanded research opportunities.

It will also lead the medical industry to view cannabis as a legal and useful means of treating patients. This could help discourage doctors from using opioids for pain and use something developed from cannabis that is much less addictive.

Another advantage is that this gives law firms a little more leeway and a certain amount of expansion, even in the short term. The hope is to push out the gray players who are causing problems. This currently affects the flow of pre-made products from manufacturer to seller to consumer – some trade-offs and products are not quite the same as those on traditional store shelves. Replanning will allow for more control and safer products.

“Legalization represents a step change toward a safer, more accessible and consumer-friendly cannabis market,” said Bob Groesbeck, Co-CEO of Planet 13. “Legalization would not only have a significant economic impact, but would also provide major benefits to cannabis consumers.” “Because legal status ensures products undergo rigorous safety and quality testing, consumers can access products that meet rigorous standards with peace of mind.

RELATED: The cannabis industry employs the same people as these companies

A benefit that will not be apparent in the near future is a price reduction. Since it is a growing industry, most families and families need additional money to stabilize and grow. Although sales may occur, the benefit to the consumer is a healthy shop/product manufacturer that lasts longer.

“Cannabis policy is a burning question for a small minority of the public, but data shows that the vast majority (nearly 90% of candidates) in congressional campaigns never publicly mention cannabis policy. This suggests that most voters are focused on different issues. “Nevertheless, the current federal cannabis transition petition initiated by President Biden is moving at lightning speed compared to any other cannabis transition petition before it,” said John Hudak, Director, Maine Office of Cannabis Policy.